Walter Sebald

Title: Walter Sebald: Innovator in Bone Morphogenetic Proteins

Introduction

Walter Sebald is a notable inventor based in Würzburg, Germany. He has made significant contributions to the field of bone morphogenetic proteins, holding a total of 5 patents. His work focuses on innovative polypeptide variants that have applications in medical science.

Latest Patents

Sebald's latest patents include a mutein of a bone morphogenetic protein, which features an amino acid substitution compared to the wildtype of the bone morphogenetic protein at the amino acid position corresponding to amino acid position 51 of human BMP-2. This invention aims to enhance the therapeutic potential of bone morphogenetic proteins. Another significant patent involves polypeptide variants with increased heparin-binding capacity. This invention is particularly relevant for stimulating chondrogenesis, osteogenesis, and wound healing. It also encompasses amino acid molecules that encode these polypeptide variants, host cells containing said nucleic acid molecules, and processes for producing the polypeptide variants.

Career Highlights

Walter Sebald has worked with several prominent organizations throughout his career. Notably, he has been associated with Osteopharma Inc. and Julius-Maximilians-Universität Würzburg. His work in these institutions has contributed to advancements in the understanding and application of bone morphogenetic proteins.

Collaborations

Sebald has collaborated with notable colleagues, including Thomas Muller and Helena Domingues. These partnerships have further enriched his research and development efforts in the field.

Conclusion

Walter Sebald's innovative work in the realm of bone morphogenetic proteins has led to significant advancements in medical science. His contributions continue to influence the development of therapeutic applications in regenerative medicine.